Technology Research Personalized Treatment Glucose Monitoring & Insulin Delivery Therapeutic Discovery and Development

AACE 2026: AI moves from hype to reality in diabetes care

"Right now, AI is more of a copilot, but the long-term vision is something much closer to autopilot."

April 23, 2026 By Matthew Solan 4 min read

Overview

The integration of AI in diabetes management is showing promising clinical relevance, particularly in insulin titration and patient engagement. AI tools are beginning to demonstrate measurable improvements in glycemic control and patient adherence, suggesting a shift towards more personalized diabetes care.

Background

The rapid increase in health data generated by diabetes technologies, such as continuous glucose monitors (CGMs) and automated insulin delivery systems, presents both opportunities and challenges in diabetes management. This data proliferation necessitates innovative approaches to effectively interpret and utilize the information for improved patient outcomes. AI's ability to analyze complex data patterns positions it as a valuable tool in addressing the clinical complexities of diabetes care.

Data Highlights

No specific numerical data or trial data provided in the source material.

Key Findings

AI-supported insulin titration can improve adherence and efficiency in reaching target doses.
AI-enabled interpretation of CGM data can identify clinically meaningful patterns that inform individualized management strategies.
AI-based insulin dosing recommendations have shown outcomes comparable to those achieved by endocrinologists.
AI-powered lifestyle interventions have demonstrated effectiveness similar to traditional programs, with higher engagement rates.
Neural networks may enhance automated insulin delivery systems by requiring less computational power while maintaining performance.

Clinical Implications

Healthcare professionals should consider integrating AI tools into their diabetes management practices to enhance patient engagement and optimize insulin therapy. The ability of AI to provide personalized interventions may address longstanding challenges in medication adherence and glycemic control.

Conclusion

AI is becoming an integral part of diabetes management, with the potential to significantly improve patient outcomes. As technology evolves, the role of AI in clinical practice is expected to expand, moving towards more autonomous management systems.

References

AACE Endocrine AI is published by Conexiant under a license arrangement with the American Association of Clinical Endocrinology, Inc. (AACE^®). The ideas and opinions expressed in AACE Endocrine AI do not necessarily reflect those of Conexiant or AACE. For more information, see Policies.